Lifecome Biochemistry Co.,Ltd. (SHE:002868)

Lifecome Biochemistry Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.33	24.8	84.38	23.76	97.5	194.26
Cash & Short-Term Investments	12.33	24.8	84.38	23.76	97.5	194.26
Cash Growth	-61.82%	-70.61%	255.14%	-75.63%	-49.81%	-55.58%
Accounts Receivable	61.97	76.83	128.42	60.06	44.86	34.12
Other Receivables	17.03	17.52	59.82	2.76	19.56	17.88
Receivables	79	94.36	188.24	62.82	64.42	52.01
Inventory	105.88	95.71	201.89	89.06	61.2	53.53
Other Current Assets	2.7	1.36	3.87	330.16	4.86	4.78
Total Current Assets	199.9	216.22	478.39	505.8	227.97	304.58
Property, Plant & Equipment	1,035	1,062	1,150	633.54	907.87	512.03
Long-Term Investments	52.55	51.65	44.75	48.57	59.14	81.09
Goodwill	-	-	61.6	-	-	-
Other Intangible Assets	120.39	125.58	132.21	31.4	40.86	42.08
Long-Term Deferred Tax Assets	11.88	11.05	30.96	7.47	9.15	2.67
Long-Term Deferred Charges	12.78	12.49	0.8	0.19	2.03	-
Other Long-Term Assets	12.4	12.49	66.79	12.9	11.39	30.06
Total Assets	1,445	1,492	1,965	1,240	1,258	972.5
Accounts Payable	326.92	315.72	310.09	136.11	167.7	80.38
Accrued Expenses	11.11	17.12	12.56	7.95	9.79	9.43
Short-Term Debt	320.97	296.76	387.77	202.93	156.28	5.01
Current Portion of Long-Term Debt	538.77	479.08	85.47	41.71	37.16	20.07
Current Portion of Leases	-	4.36	1.31	0.08	0.07	-
Current Income Taxes Payable	5.38	-	-	-	-	1.98
Current Unearned Revenue	7.98	17.06	1.51	2.81	0.91	3.63
Other Current Liabilities	7.31	112.6	131.61	93.54	18.42	6.33
Total Current Liabilities	1,218	1,243	930.31	485.14	390.34	126.82
Long-Term Debt	126.4	133.92	490.25	105.88	96.99	57
Long-Term Leases	121.06	106.1	121.9	45	30.69	-
Long-Term Unearned Revenue	29.2	30.02	3.47	4.32	9.63	10.51
Long-Term Deferred Tax Liabilities	3.27	3.46	4.96	0.22	8.73	8.23
Total Liabilities	1,498	1,516	1,551	640.56	536.38	202.56
Common Stock	155.42	155.42	155.42	155.42	155.42	155.42
Additional Paid-In Capital	349.71	349.47	345.46	340.47	340.47	340.47
Retained Earnings	-567.77	-538.36	-93.5	128.32	250.26	297.78
Treasury Stock	-	-	-	-32.43	-32.43	-32.43
Comprehensive Income & Other	7.2	7.2	3.91	3.91	3.91	3.91
Total Common Equity	-55.44	-26.27	411.29	595.69	717.63	765.15
Minority Interest	1.83	1.73	2.82	3.61	4.4	4.8
Shareholders' Equity	-53.61	-24.54	414.11	599.3	722.02	769.94
Total Liabilities & Equity	1,445	1,492	1,965	1,240	1,258	972.5
Total Debt	1,107	1,020	1,087	395.6	321.19	82.08
Net Cash (Debt)	-1,095	-995.43	-1,002	-371.84	-223.7	112.19
Net Cash Growth	-	-	-	-	-	-64.44%
Net Cash Per Share	-7.06	-6.40	-6.51	-2.41	-1.46	0.73
Filing Date Shares Outstanding	155.42	155.42	155.42	153.4	153.4	153.4
Total Common Shares Outstanding	155.42	155.42	155.42	153.4	153.4	153.4
Working Capital	-1,019	-1,026	-451.92	20.66	-162.36	177.76
Book Value Per Share	-0.36	-0.17	2.65	3.88	4.68	4.99
Tangible Book Value	-175.83	-151.84	217.48	564.29	676.77	723.07
Tangible Book Value Per Share	-1.13	-0.98	1.40	3.68	4.41	4.71
Buildings	-	543.18	479.28	406.53	206.45	194.69
Machinery	-	890.18	657.2	585.29	310.2	290.91
Construction In Progress	-	55.9	410.78	6.2	709.64	315.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.